Loading the map…
Research and experimental development on biotechnology · London
Moonlake Immunotherapeutics
Moonlake Immunotherapeutics Ltd
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2021 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
History
| £ | 2021 |
|---|---|
| Profit after tax | — |
| Turnover | |
| Net assets | |
| Cash | |
| Employees | |
| Retained reserves |
Every figure for the year
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2021 |
|---|---|
| Current assets | |
| of which debtors | |
| of which cash | |
| Creditors due within a year | |
| Net current assets | |
| Net assets | |
| Ratios | |
| Current ratioCurrent assets for every £1 owed within a year | |
| Cash ratioCash for every £1 owed within a year | |
6 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-27
- AccountsFull accounts made up to 31 December 2025
- FilingMemorandum and Articles of Association
- FilingResolutions
- ChargesRegistration of charge 135027000001, created on 20 February 2026
- AccountsTotal exemption full accounts made up to 31 December 2024
- AccountsTotal exemption full accounts made up to 31 December 2023
- AccountsTotal exemption full accounts made up to 31 December 2022
- OwnershipChange of details for Moonlake Immunotherapeutics Ag as a person with significant control on 8 July 2022
- AccountsTotal exemption full accounts made up to 31 December 2021
- AccountsPrevious accounting period shortened from 31 July 2022 to 31 December 2021
- DirectorsDirector's details changed for Matthias Bodenstedt on 16 November 2021
- DirectorsAppointment of Nuala Elizabeth Brennan as a director on 1 September 2021
3 earlier
- DirectorsAppointment of Matthias Bodenstedt as a director on 1 September 2021
- DirectorsTermination of appointment of Arnout Michiel Ploos Van Amstel as a director on 1 September 2021
- IncorporationIncorporation
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Moonlake Immunotherapeutics do?
Private limited company registered in London, classed under “Research and experimental development on biotechnology”.
›How much turnover does Moonlake Immunotherapeutics make?
Answered in the full report
›Is Moonlake Immunotherapeutics profitable?
Moonlake Immunotherapeutics's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Moonlake Immunotherapeutics?
Answered in the full report
›Who runs and owns Moonlake Immunotherapeutics?
Its directors are Matthias Bodenstedt, Nuala Elizabeth Brennan. Its owners are shown to subscribers.
›Where is Moonlake Immunotherapeutics based?
Its registered office is 3rd Floor, 114a Cromwell Road, London, SW7 4AG, in London.
›When was Moonlake Immunotherapeutics founded?
Moonlake Immunotherapeutics Ltd was incorporated on 9 July 2021.
›Is Moonlake Immunotherapeutics still trading?
The register lists Moonlake Immunotherapeutics Ltd as active.